These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23037949)

  • 21. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option?
    Lee VD; Northup PG; Berg CL
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1069-71. PubMed ID: 16793346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
    Stoll AL; Sachs GS; Cohen BM; Lafer B; Christensen JD; Renshaw PF
    Biol Psychiatry; 1996 Sep; 40(5):382-8. PubMed ID: 8874839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in hypothyroidism between lithium-free and -treated patients with bipolar disorders.
    Zhang ZJ; Qiang Li ; Kang WH; Tan QR; Gao CG; Zhang FG; Wang HH; Ma XC; Ce Chen ; Wei Wang ; Li Guo ; Zhang YH; Yang XB; Zhang RG
    Life Sci; 2006 Jan; 78(7):771-6. PubMed ID: 16137715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression in hepatolenticular degeneration (Wilson's disease).
    Walter G; Lyndon B
    Aust N Z J Psychiatry; 1997 Dec; 31(6):880-2. PubMed ID: 9483264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition and treatment of neurologic Wilson's disease.
    Lorincz MT
    Semin Neurol; 2012 Nov; 32(5):538-43. PubMed ID: 23677665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stutter exacerbated by lithium in a pediatric patient with bipolar disorder.
    Gulack BC; Puri NV; Kim WJ
    Ann Pharmacother; 2011 Oct; 45(10):e57. PubMed ID: 21917558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder.
    Kato T; Hamakawa H; Shioiri T; Murashita J; Takahashi Y; Takahashi S; Inubushi T
    J Psychiatry Neurosci; 1996 Jul; 21(4):248-54. PubMed ID: 8754593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol.
    Colla M; Schubert F; Bubner M; Heidenreich JO; Bajbouj M; Seifert F; Luborzewski A; Heuser I; Kronenberg G
    Mol Psychiatry; 2009 Jul; 14(7):696-704, 647. PubMed ID: 18347601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mixed episodes in bipolar disorder: a review].
    Merkl A; Regen F; Schindler F; Krüger S; Anghelescu I
    Fortschr Neurol Psychiatr; 2007 Jun; 75(6):323-30. PubMed ID: 17031775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine production in bipolar affective disorder patients under lithium treatment.
    Boufidou F; Nikolaou C; Alevizos B; Liappas IA; Christodoulou GN
    J Affect Disord; 2004 Oct; 82(2):309-13. PubMed ID: 15488263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of bipolar disorder: how far have we come?
    Hopkins HS; Gelenberg AJ
    Psychopharmacol Bull; 1994; 30(1):27-38. PubMed ID: 7972626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late onset first manic episode: role of lithium].
    Misdrahi D; Millet B
    Encephale; 2001; 27(4):377-9. PubMed ID: 11686061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delusional disorder and alcohol abuse in a patient with Wilson's disease.
    Spyridi S; Diakogiannis I; Michaelides M; Sokolaki S; Iacovides A; Kaprinis G
    Gen Hosp Psychiatry; 2008; 30(6):585-6. PubMed ID: 19061688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status epilepticus in Wilson's disease.
    Pestana Knight EM; Gilman S; Selwa L
    Epileptic Disord; 2009 Jun; 11(2):138-43. PubMed ID: 19473947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
    Kikuchi K; Iga J; Tayoshi S; Nakataki M; Watanabe S; Numata S; Ohmori T
    Hum Psychopharmacol; 2011; 26(4-5):358-63. PubMed ID: 21721043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium.
    Loch AA; Zanetti MV; de Sousa RT; Chaim TM; Serpa MH; Gattaz WF; Teixeira AL; Machado-Vieira R
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():243-6. PubMed ID: 25290636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.